U.S. Hemophilia Treatment Market is driven by rising demand for novel therapies
The U.S. hemophilia treatment market comprises various products such as coagulation factors concentrates, desmopressin, and antifibrinolytics which are used to treat patients diagnosed with hemophilia A and hemophilia B. Treatment options in hemophilia focus on preventing excessive bleeding and providing adequate clotting factor levels. Recombinant coagulation factors have revolutionized...
0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
Προωθημένο

Trade with the best

aking Exness the first name that comes to mind when people think about brokers or trading. We’re putting our traders first, not only with trading conditions, but also with the overall...